nodes	percent_of_prediction	percent_of_DWPC	metapath
Domperidone—ABCB1—kidney cancer	0.168	1	CbGaD
Domperidone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0507	0.0718	CbGbCtD
Domperidone—CYP3A7—Temsirolimus—kidney cancer	0.0507	0.0718	CbGbCtD
Domperidone—CYP3A5—Temsirolimus—kidney cancer	0.038	0.0539	CbGbCtD
Domperidone—ABCB1—Temsirolimus—kidney cancer	0.0248	0.0351	CbGbCtD
Domperidone—KCNH2—Sunitinib—kidney cancer	0.0245	0.0347	CbGbCtD
Domperidone—CYP2D6—Temsirolimus—kidney cancer	0.0233	0.033	CbGbCtD
Domperidone—CYP3A4—Everolimus—kidney cancer	0.022	0.0311	CbGbCtD
Domperidone—CYP2C8—Pazopanib—kidney cancer	0.0192	0.0272	CbGbCtD
Domperidone—CYP3A7—Paclitaxel—kidney cancer	0.0174	0.0246	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0174	0.0246	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0155	0.0219	CbGbCtD
Domperidone—CYP3A7—Sorafenib—kidney cancer	0.0155	0.0219	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.015	0.0212	CbGbCtD
Domperidone—CYP3A7—Vincristine—kidney cancer	0.015	0.0212	CbGbCtD
Domperidone—CYP1A2—Pazopanib—kidney cancer	0.0149	0.0211	CbGbCtD
Domperidone—CYP3A4—Temsirolimus—kidney cancer	0.0148	0.021	CbGbCtD
Domperidone—CYP2B6—Sorafenib—kidney cancer	0.0147	0.0208	CbGbCtD
Domperidone—CYP3A5—Erlotinib—kidney cancer	0.0143	0.0202	CbGbCtD
Domperidone—CYP2C8—Erlotinib—kidney cancer	0.0137	0.0194	CbGbCtD
Domperidone—CYP3A5—Paclitaxel—kidney cancer	0.0131	0.0185	CbGbCtD
Domperidone—ABCB1—Pazopanib—kidney cancer	0.013	0.0184	CbGbCtD
Domperidone—CYP2C8—Paclitaxel—kidney cancer	0.0126	0.0178	CbGbCtD
Domperidone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0125	0.0177	CbGbCtD
Domperidone—CYP3A7—Sunitinib—kidney cancer	0.0125	0.0177	CbGbCtD
Domperidone—CYP2D6—Pazopanib—kidney cancer	0.0123	0.0174	CbGbCtD
Domperidone—ABCB1—Dactinomycin—kidney cancer	0.0119	0.0168	CbGbCtD
Domperidone—CYP3A5—Sorafenib—kidney cancer	0.0116	0.0164	CbGbCtD
Domperidone—CYP3A5—Vincristine—kidney cancer	0.0113	0.0159	CbGbCtD
Domperidone—CYP2C8—Sorafenib—kidney cancer	0.0111	0.0158	CbGbCtD
Domperidone—CYP1A2—Erlotinib—kidney cancer	0.0106	0.015	CbGbCtD
Domperidone—ABCB1—Gemcitabine—kidney cancer	0.0094	0.0133	CbGbCtD
Domperidone—CYP3A5—Sunitinib—kidney cancer	0.0094	0.0133	CbGbCtD
Domperidone—ABCB1—Erlotinib—kidney cancer	0.00928	0.0131	CbGbCtD
Domperidone—CYP2B6—Doxorubicin—kidney cancer	0.00893	0.0126	CbGbCtD
Domperidone—CYP2D6—Erlotinib—kidney cancer	0.00875	0.0124	CbGbCtD
Domperidone—CYP1A2—Sorafenib—kidney cancer	0.00863	0.0122	CbGbCtD
Domperidone—ABCB1—Paclitaxel—kidney cancer	0.0085	0.012	CbGbCtD
Domperidone—CYP3A4—Pazopanib—kidney cancer	0.00779	0.011	CbGbCtD
Domperidone—ABCB1—Sorafenib—kidney cancer	0.00755	0.0107	CbGbCtD
Domperidone—ABCB1—Vinblastine—kidney cancer	0.00745	0.0106	CbGbCtD
Domperidone—ABCB1—Vincristine—kidney cancer	0.00733	0.0104	CbGbCtD
Domperidone—CYP2D6—Sorafenib—kidney cancer	0.00711	0.0101	CbGbCtD
Domperidone—CYP2D6—Vinblastine—kidney cancer	0.00702	0.00994	CbGbCtD
Domperidone—ABCB1—Sunitinib—kidney cancer	0.00611	0.00866	CbGbCtD
Domperidone—CYP3A4—Erlotinib—kidney cancer	0.00556	0.00787	CbGbCtD
Domperidone—CYP3A4—Paclitaxel—kidney cancer	0.00509	0.00721	CbGbCtD
Domperidone—ABCB1—Doxorubicin—kidney cancer	0.00458	0.00648	CbGbCtD
Domperidone—CYP3A4—Sorafenib—kidney cancer	0.00452	0.0064	CbGbCtD
Domperidone—CYP3A4—Vinblastine—kidney cancer	0.00447	0.00632	CbGbCtD
Domperidone—CYP3A4—Vincristine—kidney cancer	0.00439	0.00622	CbGbCtD
Domperidone—CYP2D6—Doxorubicin—kidney cancer	0.00431	0.00611	CbGbCtD
Domperidone—CYP3A4—Sunitinib—kidney cancer	0.00366	0.00519	CbGbCtD
Domperidone—CYP3A4—Doxorubicin—kidney cancer	0.00274	0.00388	CbGbCtD
Domperidone—CYP1A2—urine—kidney cancer	0.00116	0.124	CbGeAlD
Domperidone—CYP3A4—urine—kidney cancer	0.000841	0.0896	CbGeAlD
Domperidone—CYP2D6—urine—kidney cancer	0.000827	0.0881	CbGeAlD
Domperidone—Torsade de pointes—Capecitabine—kidney cancer	0.00073	0.00781	CcSEcCtD
Domperidone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000729	0.0776	CbGeAlD
Domperidone—Hot flush—Sunitinib—kidney cancer	0.000721	0.00771	CcSEcCtD
Domperidone—Breast pain—Paclitaxel—kidney cancer	0.000715	0.00765	CcSEcCtD
Domperidone—Menopausal symptoms—Sunitinib—kidney cancer	0.000715	0.00764	CcSEcCtD
Domperidone—Dysuria—Everolimus—kidney cancer	0.000653	0.00697	CcSEcCtD
Domperidone—Lethargy—Dactinomycin—kidney cancer	0.000652	0.00696	CcSEcCtD
Domperidone—Pollakiuria—Everolimus—kidney cancer	0.000645	0.00689	CcSEcCtD
Domperidone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000624	0.0664	CbGeAlD
Domperidone—Stomatitis—Everolimus—kidney cancer	0.000607	0.00648	CcSEcCtD
Domperidone—Conjunctivitis—Everolimus—kidney cancer	0.000605	0.00646	CcSEcCtD
Domperidone—Muscle spasms—Pazopanib—kidney cancer	0.000592	0.00633	CcSEcCtD
Domperidone—Stomatitis—Erlotinib—kidney cancer	0.000585	0.00625	CcSEcCtD
Domperidone—Conjunctivitis—Erlotinib—kidney cancer	0.000584	0.00624	CcSEcCtD
Domperidone—Cramps of lower extremities—Paclitaxel—kidney cancer	0.000573	0.00613	CcSEcCtD
Domperidone—Oedema—Temsirolimus—kidney cancer	0.000534	0.0057	CcSEcCtD
Domperidone—Stomatitis—Sorafenib—kidney cancer	0.000526	0.00563	CcSEcCtD
Domperidone—Dry mouth—Pazopanib—kidney cancer	0.000513	0.00548	CcSEcCtD
Domperidone—Stomatitis—Sunitinib—kidney cancer	0.000507	0.00541	CcSEcCtD
Domperidone—Oedema—Pazopanib—kidney cancer	0.000503	0.00537	CcSEcCtD
Domperidone—Hot flush—Paclitaxel—kidney cancer	0.000484	0.00518	CcSEcCtD
Domperidone—Insomnia—Temsirolimus—kidney cancer	0.000483	0.00516	CcSEcCtD
Domperidone—Arrhythmia—Erlotinib—kidney cancer	0.000481	0.00515	CcSEcCtD
Domperidone—Menopausal symptoms—Paclitaxel—kidney cancer	0.00048	0.00513	CcSEcCtD
Domperidone—Stomatitis—Dactinomycin—kidney cancer	0.00048	0.00513	CcSEcCtD
Domperidone—Somnolence—Temsirolimus—kidney cancer	0.000474	0.00507	CcSEcCtD
Domperidone—Muscle spasms—Everolimus—kidney cancer	0.000468	0.005	CcSEcCtD
Domperidone—Lethargy—Paclitaxel—kidney cancer	0.000462	0.00494	CcSEcCtD
Domperidone—Dysuria—Vincristine—kidney cancer	0.000461	0.00493	CcSEcCtD
Domperidone—Constipation—Temsirolimus—kidney cancer	0.000456	0.00488	CcSEcCtD
Domperidone—Insomnia—Pazopanib—kidney cancer	0.000455	0.00486	CcSEcCtD
Domperidone—Somnolence—Pazopanib—kidney cancer	0.000447	0.00478	CcSEcCtD
Domperidone—Dyspepsia—Pazopanib—kidney cancer	0.000442	0.00473	CcSEcCtD
Domperidone—Arrhythmia—Sorafenib—kidney cancer	0.000433	0.00463	CcSEcCtD
Domperidone—Palpitations—Everolimus—kidney cancer	0.00043	0.00459	CcSEcCtD
Domperidone—Stomatitis—Vincristine—kidney cancer	0.000428	0.00458	CcSEcCtD
Domperidone—Abdominal pain—Temsirolimus—kidney cancer	0.000422	0.00451	CcSEcCtD
Domperidone—Arrhythmia—Sunitinib—kidney cancer	0.000417	0.00445	CcSEcCtD
Domperidone—Stomatitis—Gemcitabine—kidney cancer	0.000406	0.00434	CcSEcCtD
Domperidone—Muscle spasms—Sorafenib—kidney cancer	0.000406	0.00434	CcSEcCtD
Domperidone—Dry mouth—Everolimus—kidney cancer	0.000405	0.00433	CcSEcCtD
Domperidone—Hot flush—Capecitabine—kidney cancer	0.000397	0.00425	CcSEcCtD
Domperidone—Abdominal pain—Pazopanib—kidney cancer	0.000397	0.00425	CcSEcCtD
Domperidone—Oedema—Everolimus—kidney cancer	0.000397	0.00424	CcSEcCtD
Domperidone—Menopausal symptoms—Capecitabine—kidney cancer	0.000394	0.00421	CcSEcCtD
Domperidone—Thirst—Capecitabine—kidney cancer	0.000391	0.00418	CcSEcCtD
Domperidone—Muscle spasms—Sunitinib—kidney cancer	0.00039	0.00417	CcSEcCtD
Domperidone—Oedema—Erlotinib—kidney cancer	0.000383	0.00409	CcSEcCtD
Domperidone—Asthenia—Temsirolimus—kidney cancer	0.000383	0.00409	CcSEcCtD
Domperidone—Lethargy—Capecitabine—kidney cancer	0.000379	0.00406	CcSEcCtD
Domperidone—Breast pain—Doxorubicin—kidney cancer	0.000378	0.00404	CcSEcCtD
Domperidone—Pruritus—Temsirolimus—kidney cancer	0.000377	0.00403	CcSEcCtD
Domperidone—Hypotension—Everolimus—kidney cancer	0.000371	0.00396	CcSEcCtD
Domperidone—Dysuria—Paclitaxel—kidney cancer	0.000366	0.00391	CcSEcCtD
Domperidone—Migraine—Capecitabine—kidney cancer	0.000366	0.00391	CcSEcCtD
Domperidone—Diarrhoea—Temsirolimus—kidney cancer	0.000365	0.0039	CcSEcCtD
Domperidone—Pollakiuria—Paclitaxel—kidney cancer	0.000362	0.00387	CcSEcCtD
Domperidone—Asthenia—Pazopanib—kidney cancer	0.000361	0.00385	CcSEcCtD
Domperidone—Insomnia—Everolimus—kidney cancer	0.000359	0.00384	CcSEcCtD
Domperidone—Pruritus—Pazopanib—kidney cancer	0.000356	0.0038	CcSEcCtD
Domperidone—Irritability—Capecitabine—kidney cancer	0.000355	0.00379	CcSEcCtD
Domperidone—Somnolence—Everolimus—kidney cancer	0.000353	0.00377	CcSEcCtD
Domperidone—Dizziness—Temsirolimus—kidney cancer	0.000353	0.00377	CcSEcCtD
Domperidone—Dry mouth—Sorafenib—kidney cancer	0.000351	0.00376	CcSEcCtD
Domperidone—Dyspepsia—Everolimus—kidney cancer	0.000349	0.00373	CcSEcCtD
Domperidone—Insomnia—Erlotinib—kidney cancer	0.000346	0.0037	CcSEcCtD
Domperidone—Diarrhoea—Pazopanib—kidney cancer	0.000344	0.00368	CcSEcCtD
Domperidone—Constipation—Vinblastine—kidney cancer	0.000341	0.00364	CcSEcCtD
Domperidone—Stomatitis—Paclitaxel—kidney cancer	0.00034	0.00364	CcSEcCtD
Domperidone—Conjunctivitis—Paclitaxel—kidney cancer	0.000339	0.00363	CcSEcCtD
Domperidone—Constipation—Everolimus—kidney cancer	0.000339	0.00363	CcSEcCtD
Domperidone—Vomiting—Temsirolimus—kidney cancer	0.000339	0.00363	CcSEcCtD
Domperidone—Dry mouth—Sunitinib—kidney cancer	0.000338	0.00361	CcSEcCtD
Domperidone—Dyspepsia—Erlotinib—kidney cancer	0.000337	0.0036	CcSEcCtD
Domperidone—Rash—Temsirolimus—kidney cancer	0.000336	0.0036	CcSEcCtD
Domperidone—Dermatitis—Temsirolimus—kidney cancer	0.000336	0.00359	CcSEcCtD
Domperidone—Arrhythmia—Gemcitabine—kidney cancer	0.000334	0.00357	CcSEcCtD
Domperidone—Headache—Temsirolimus—kidney cancer	0.000334	0.00357	CcSEcCtD
Domperidone—Dizziness—Pazopanib—kidney cancer	0.000332	0.00355	CcSEcCtD
Domperidone—KCNH2—renal system—kidney cancer	0.000332	0.0354	CbGeAlD
Domperidone—Oedema—Sunitinib—kidney cancer	0.000331	0.00354	CcSEcCtD
Domperidone—Constipation—Erlotinib—kidney cancer	0.000327	0.0035	CcSEcCtD
Domperidone—Vomiting—Pazopanib—kidney cancer	0.00032	0.00342	CcSEcCtD
Domperidone—Rash—Pazopanib—kidney cancer	0.000317	0.00339	CcSEcCtD
Domperidone—Nausea—Temsirolimus—kidney cancer	0.000317	0.00339	CcSEcCtD
Domperidone—Dermatitis—Pazopanib—kidney cancer	0.000317	0.00338	CcSEcCtD
Domperidone—Abdominal pain—Vinblastine—kidney cancer	0.000315	0.00337	CcSEcCtD
Domperidone—Headache—Pazopanib—kidney cancer	0.000315	0.00337	CcSEcCtD
Domperidone—Oedema—Dactinomycin—kidney cancer	0.000314	0.00335	CcSEcCtD
Domperidone—Abdominal pain—Everolimus—kidney cancer	0.000314	0.00335	CcSEcCtD
Domperidone—CYP2C8—renal system—kidney cancer	0.000304	0.0323	CbGeAlD
Domperidone—Cramps of lower extremities—Doxorubicin—kidney cancer	0.000303	0.00324	CcSEcCtD
Domperidone—Dyspepsia—Sorafenib—kidney cancer	0.000303	0.00324	CcSEcCtD
Domperidone—Abdominal pain—Erlotinib—kidney cancer	0.000303	0.00324	CcSEcCtD
Domperidone—CYP3A5—nephron tubule—kidney cancer	0.000302	0.0321	CbGeAlD
Domperidone—Dysuria—Capecitabine—kidney cancer	0.0003	0.00321	CcSEcCtD
Domperidone—Insomnia—Sunitinib—kidney cancer	0.0003	0.0032	CcSEcCtD
Domperidone—CYP2B6—nephron tubule—kidney cancer	0.0003	0.0319	CbGeAlD
Domperidone—Nausea—Pazopanib—kidney cancer	0.000299	0.00319	CcSEcCtD
Domperidone—KCNH2—cardiac atrium—kidney cancer	0.000297	0.0317	CbGeAlD
Domperidone—Constipation—Sorafenib—kidney cancer	0.000295	0.00315	CcSEcCtD
Domperidone—CYP2C8—kidney—kidney cancer	0.000294	0.0313	CbGeAlD
Domperidone—Dyspepsia—Sunitinib—kidney cancer	0.000292	0.00312	CcSEcCtD
Domperidone—Asthenia—Vinblastine—kidney cancer	0.000286	0.00306	CcSEcCtD
Domperidone—Asthenia—Everolimus—kidney cancer	0.000285	0.00304	CcSEcCtD
Domperidone—CYP1A2—renal system—kidney cancer	0.000284	0.0303	CbGeAlD
Domperidone—Constipation—Sunitinib—kidney cancer	0.000283	0.00303	CcSEcCtD
Domperidone—Pruritus—Everolimus—kidney cancer	0.000281	0.003	CcSEcCtD
Domperidone—Oedema—Vincristine—kidney cancer	0.00028	0.003	CcSEcCtD
Domperidone—Arrhythmia—Paclitaxel—kidney cancer	0.00028	0.00299	CcSEcCtD
Domperidone—Stomatitis—Capecitabine—kidney cancer	0.000279	0.00299	CcSEcCtD
Domperidone—Conjunctivitis—Capecitabine—kidney cancer	0.000279	0.00298	CcSEcCtD
Domperidone—Asthenia—Erlotinib—kidney cancer	0.000275	0.00294	CcSEcCtD
Domperidone—CYP3A5—renal system—kidney cancer	0.000274	0.0292	CbGeAlD
Domperidone—Urticaria—Sorafenib—kidney cancer	0.000274	0.00292	CcSEcCtD
Domperidone—Diarrhoea—Vinblastine—kidney cancer	0.000273	0.00291	CcSEcCtD
Domperidone—CYP2B6—renal system—kidney cancer	0.000272	0.029	CbGeAlD
Domperidone—Abdominal pain—Sorafenib—kidney cancer	0.000272	0.00291	CcSEcCtD
Domperidone—Diarrhoea—Everolimus—kidney cancer	0.000272	0.0029	CcSEcCtD
Domperidone—Pruritus—Erlotinib—kidney cancer	0.000271	0.0029	CcSEcCtD
Domperidone—Tension—Paclitaxel—kidney cancer	0.000268	0.00286	CcSEcCtD
Domperidone—Oedema—Gemcitabine—kidney cancer	0.000266	0.00284	CcSEcCtD
Domperidone—CYP3A5—kidney—kidney cancer	0.000265	0.0282	CbGeAlD
Domperidone—Nervousness—Paclitaxel—kidney cancer	0.000265	0.00283	CcSEcCtD
Domperidone—Dizziness—Vinblastine—kidney cancer	0.000263	0.00282	CcSEcCtD
Domperidone—CYP2B6—kidney—kidney cancer	0.000263	0.0281	CbGeAlD
Domperidone—Dizziness—Everolimus—kidney cancer	0.000262	0.0028	CcSEcCtD
Domperidone—Muscle spasms—Paclitaxel—kidney cancer	0.000262	0.0028	CcSEcCtD
Domperidone—Abdominal pain—Sunitinib—kidney cancer	0.000262	0.0028	CcSEcCtD
Domperidone—Diarrhoea—Erlotinib—kidney cancer	0.000262	0.0028	CcSEcCtD
Domperidone—Hypotension—Vincristine—kidney cancer	0.000262	0.0028	CcSEcCtD
Domperidone—CYP3A5—cortex of kidney—kidney cancer	0.000258	0.0275	CbGeAlD
Domperidone—Hot flush—Doxorubicin—kidney cancer	0.000256	0.00274	CcSEcCtD
Domperidone—Menopausal symptoms—Doxorubicin—kidney cancer	0.000254	0.00271	CcSEcCtD
Domperidone—Insomnia—Vincristine—kidney cancer	0.000254	0.00271	CcSEcCtD
Domperidone—Vomiting—Vinblastine—kidney cancer	0.000253	0.00271	CcSEcCtD
Domperidone—Dizziness—Erlotinib—kidney cancer	0.000253	0.00271	CcSEcCtD
Domperidone—Vomiting—Everolimus—kidney cancer	0.000252	0.0027	CcSEcCtD
Domperidone—Rash—Everolimus—kidney cancer	0.00025	0.00267	CcSEcCtD
Domperidone—Dermatitis—Everolimus—kidney cancer	0.00025	0.00267	CcSEcCtD
Domperidone—Headache—Vinblastine—kidney cancer	0.00025	0.00267	CcSEcCtD
Domperidone—Headache—Everolimus—kidney cancer	0.000249	0.00266	CcSEcCtD
Domperidone—Hypotension—Gemcitabine—kidney cancer	0.000249	0.00266	CcSEcCtD
Domperidone—Abdominal pain—Dactinomycin—kidney cancer	0.000248	0.00265	CcSEcCtD
Domperidone—Asthenia—Sorafenib—kidney cancer	0.000247	0.00264	CcSEcCtD
Domperidone—Lethargy—Doxorubicin—kidney cancer	0.000245	0.00261	CcSEcCtD
Domperidone—CYP2B6—gonad—kidney cancer	0.000244	0.026	CbGeAlD
Domperidone—Pruritus—Sorafenib—kidney cancer	0.000244	0.0026	CcSEcCtD
Domperidone—Vomiting—Erlotinib—kidney cancer	0.000243	0.0026	CcSEcCtD
Domperidone—Rash—Erlotinib—kidney cancer	0.000241	0.00258	CcSEcCtD
Domperidone—Dermatitis—Erlotinib—kidney cancer	0.000241	0.00258	CcSEcCtD
Domperidone—Palpitations—Paclitaxel—kidney cancer	0.000241	0.00258	CcSEcCtD
Domperidone—Insomnia—Gemcitabine—kidney cancer	0.000241	0.00257	CcSEcCtD
Domperidone—Headache—Erlotinib—kidney cancer	0.00024	0.00256	CcSEcCtD
Domperidone—Constipation—Vincristine—kidney cancer	0.00024	0.00256	CcSEcCtD
Domperidone—Asthenia—Sunitinib—kidney cancer	0.000238	0.00254	CcSEcCtD
Domperidone—Nausea—Vinblastine—kidney cancer	0.000237	0.00253	CcSEcCtD
Domperidone—Somnolence—Gemcitabine—kidney cancer	0.000236	0.00253	CcSEcCtD
Domperidone—Migraine—Doxorubicin—kidney cancer	0.000236	0.00252	CcSEcCtD
Domperidone—Nausea—Everolimus—kidney cancer	0.000236	0.00252	CcSEcCtD
Domperidone—Diarrhoea—Sorafenib—kidney cancer	0.000236	0.00252	CcSEcCtD
Domperidone—Pruritus—Sunitinib—kidney cancer	0.000235	0.00251	CcSEcCtD
Domperidone—Arrhythmia—Capecitabine—kidney cancer	0.00023	0.00246	CcSEcCtD
Domperidone—Dizziness—Sorafenib—kidney cancer	0.000228	0.00243	CcSEcCtD
Domperidone—Constipation—Gemcitabine—kidney cancer	0.000227	0.00243	CcSEcCtD
Domperidone—Nausea—Erlotinib—kidney cancer	0.000227	0.00243	CcSEcCtD
Domperidone—Dry mouth—Paclitaxel—kidney cancer	0.000227	0.00243	CcSEcCtD
Domperidone—Diarrhoea—Sunitinib—kidney cancer	0.000227	0.00242	CcSEcCtD
Domperidone—Asthenia—Dactinomycin—kidney cancer	0.000225	0.00241	CcSEcCtD
Domperidone—Oedema—Paclitaxel—kidney cancer	0.000223	0.00238	CcSEcCtD
Domperidone—Abdominal pain—Vincristine—kidney cancer	0.000222	0.00237	CcSEcCtD
Domperidone—Dizziness—Sunitinib—kidney cancer	0.000219	0.00234	CcSEcCtD
Domperidone—Vomiting—Sorafenib—kidney cancer	0.000219	0.00234	CcSEcCtD
Domperidone—Rash—Sorafenib—kidney cancer	0.000217	0.00232	CcSEcCtD
Domperidone—Dermatitis—Sorafenib—kidney cancer	0.000217	0.00232	CcSEcCtD
Domperidone—Headache—Sorafenib—kidney cancer	0.000216	0.00231	CcSEcCtD
Domperidone—Muscle spasms—Capecitabine—kidney cancer	0.000215	0.0023	CcSEcCtD
Domperidone—Diarrhoea—Dactinomycin—kidney cancer	0.000215	0.00229	CcSEcCtD
Domperidone—Vomiting—Sunitinib—kidney cancer	0.000211	0.00225	CcSEcCtD
Domperidone—Rash—Sunitinib—kidney cancer	0.000209	0.00223	CcSEcCtD
Domperidone—Dermatitis—Sunitinib—kidney cancer	0.000209	0.00223	CcSEcCtD
Domperidone—Hypotension—Paclitaxel—kidney cancer	0.000208	0.00222	CcSEcCtD
Domperidone—Headache—Sunitinib—kidney cancer	0.000208	0.00222	CcSEcCtD
Domperidone—CYP3A4—renal system—kidney cancer	0.000206	0.0219	CbGeAlD
Domperidone—Nausea—Sorafenib—kidney cancer	0.000205	0.00219	CcSEcCtD
Domperidone—CYP2D6—renal system—kidney cancer	0.000202	0.0216	CbGeAlD
Domperidone—Insomnia—Paclitaxel—kidney cancer	0.000201	0.00215	CcSEcCtD
Domperidone—Asthenia—Vincristine—kidney cancer	0.000201	0.00215	CcSEcCtD
Domperidone—Vomiting—Dactinomycin—kidney cancer	0.0002	0.00213	CcSEcCtD
Domperidone—CYP3A4—kidney—kidney cancer	0.000199	0.0212	CbGeAlD
Domperidone—Somnolence—Paclitaxel—kidney cancer	0.000198	0.00212	CcSEcCtD
Domperidone—Palpitations—Capecitabine—kidney cancer	0.000198	0.00211	CcSEcCtD
Domperidone—Rash—Dactinomycin—kidney cancer	0.000198	0.00211	CcSEcCtD
Domperidone—Nausea—Sunitinib—kidney cancer	0.000197	0.0021	CcSEcCtD
Domperidone—Dyspepsia—Paclitaxel—kidney cancer	0.000196	0.0021	CcSEcCtD
Domperidone—CYP2D6—kidney—kidney cancer	0.000196	0.0208	CbGeAlD
Domperidone—Dysuria—Doxorubicin—kidney cancer	0.000194	0.00207	CcSEcCtD
Domperidone—Diarrhoea—Vincristine—kidney cancer	0.000192	0.00205	CcSEcCtD
Domperidone—Pollakiuria—Doxorubicin—kidney cancer	0.000191	0.00205	CcSEcCtD
Domperidone—Asthenia—Gemcitabine—kidney cancer	0.000191	0.00204	CcSEcCtD
Domperidone—Constipation—Paclitaxel—kidney cancer	0.00019	0.00204	CcSEcCtD
Domperidone—Pruritus—Gemcitabine—kidney cancer	0.000188	0.00201	CcSEcCtD
Domperidone—Dry mouth—Capecitabine—kidney cancer	0.000186	0.00199	CcSEcCtD
Domperidone—Nausea—Dactinomycin—kidney cancer	0.000186	0.00199	CcSEcCtD
Domperidone—Dizziness—Vincristine—kidney cancer	0.000185	0.00198	CcSEcCtD
Domperidone—Drowsiness—Doxorubicin—kidney cancer	0.000185	0.00197	CcSEcCtD
Domperidone—Oedema—Capecitabine—kidney cancer	0.000183	0.00195	CcSEcCtD
Domperidone—Diarrhoea—Gemcitabine—kidney cancer	0.000182	0.00195	CcSEcCtD
Domperidone—Stomatitis—Doxorubicin—kidney cancer	0.00018	0.00192	CcSEcCtD
Domperidone—Conjunctivitis—Doxorubicin—kidney cancer	0.00018	0.00192	CcSEcCtD
Domperidone—Vomiting—Vincristine—kidney cancer	0.000178	0.00191	CcSEcCtD
Domperidone—Urticaria—Paclitaxel—kidney cancer	0.000177	0.00189	CcSEcCtD
Domperidone—Rash—Vincristine—kidney cancer	0.000177	0.00189	CcSEcCtD
Domperidone—Dermatitis—Vincristine—kidney cancer	0.000177	0.00189	CcSEcCtD
Domperidone—Abdominal pain—Paclitaxel—kidney cancer	0.000176	0.00188	CcSEcCtD
Domperidone—Headache—Vincristine—kidney cancer	0.000176	0.00188	CcSEcCtD
Domperidone—Hypotension—Capecitabine—kidney cancer	0.000171	0.00183	CcSEcCtD
Domperidone—Vomiting—Gemcitabine—kidney cancer	0.000169	0.00181	CcSEcCtD
Domperidone—Rash—Gemcitabine—kidney cancer	0.000168	0.00179	CcSEcCtD
Domperidone—Dermatitis—Gemcitabine—kidney cancer	0.000168	0.00179	CcSEcCtD
Domperidone—Headache—Gemcitabine—kidney cancer	0.000167	0.00178	CcSEcCtD
Domperidone—Nausea—Vincristine—kidney cancer	0.000167	0.00178	CcSEcCtD
Domperidone—Insomnia—Capecitabine—kidney cancer	0.000165	0.00177	CcSEcCtD
Domperidone—Dyspepsia—Capecitabine—kidney cancer	0.000161	0.00172	CcSEcCtD
Domperidone—ABCB1—nephron tubule—kidney cancer	0.00016	0.0171	CbGeAlD
Domperidone—Asthenia—Paclitaxel—kidney cancer	0.00016	0.00171	CcSEcCtD
Domperidone—Nausea—Gemcitabine—kidney cancer	0.000158	0.00169	CcSEcCtD
Domperidone—Pruritus—Paclitaxel—kidney cancer	0.000158	0.00168	CcSEcCtD
Domperidone—Constipation—Capecitabine—kidney cancer	0.000156	0.00167	CcSEcCtD
Domperidone—Diarrhoea—Paclitaxel—kidney cancer	0.000152	0.00163	CcSEcCtD
Domperidone—Arrhythmia—Doxorubicin—kidney cancer	0.000148	0.00158	CcSEcCtD
Domperidone—Dizziness—Paclitaxel—kidney cancer	0.000147	0.00157	CcSEcCtD
Domperidone—ABCB1—renal system—kidney cancer	0.000146	0.0155	CbGeAlD
Domperidone—Urticaria—Capecitabine—kidney cancer	0.000145	0.00155	CcSEcCtD
Domperidone—Abdominal pain—Capecitabine—kidney cancer	0.000144	0.00154	CcSEcCtD
Domperidone—Tension—Doxorubicin—kidney cancer	0.000142	0.00151	CcSEcCtD
Domperidone—Vomiting—Paclitaxel—kidney cancer	0.000142	0.00151	CcSEcCtD
Domperidone—ABCB1—kidney—kidney cancer	0.000141	0.015	CbGeAlD
Domperidone—Rash—Paclitaxel—kidney cancer	0.00014	0.0015	CcSEcCtD
Domperidone—Dermatitis—Paclitaxel—kidney cancer	0.00014	0.0015	CcSEcCtD
Domperidone—Nervousness—Doxorubicin—kidney cancer	0.00014	0.0015	CcSEcCtD
Domperidone—Headache—Paclitaxel—kidney cancer	0.00014	0.00149	CcSEcCtD
Domperidone—Muscle spasms—Doxorubicin—kidney cancer	0.000139	0.00148	CcSEcCtD
Domperidone—ABCB1—cortex of kidney—kidney cancer	0.000137	0.0146	CbGeAlD
Domperidone—Nausea—Paclitaxel—kidney cancer	0.000132	0.00141	CcSEcCtD
Domperidone—Asthenia—Capecitabine—kidney cancer	0.000131	0.0014	CcSEcCtD
Domperidone—ABCB1—gonad—kidney cancer	0.000131	0.0139	CbGeAlD
Domperidone—Pruritus—Capecitabine—kidney cancer	0.000129	0.00138	CcSEcCtD
Domperidone—Palpitations—Doxorubicin—kidney cancer	0.000128	0.00136	CcSEcCtD
Domperidone—Diarrhoea—Capecitabine—kidney cancer	0.000125	0.00134	CcSEcCtD
Domperidone—Dizziness—Capecitabine—kidney cancer	0.000121	0.00129	CcSEcCtD
Domperidone—Dry mouth—Doxorubicin—kidney cancer	0.00012	0.00128	CcSEcCtD
Domperidone—Oedema—Doxorubicin—kidney cancer	0.000118	0.00126	CcSEcCtD
Domperidone—Vomiting—Capecitabine—kidney cancer	0.000116	0.00124	CcSEcCtD
Domperidone—Rash—Capecitabine—kidney cancer	0.000115	0.00123	CcSEcCtD
Domperidone—Dermatitis—Capecitabine—kidney cancer	0.000115	0.00123	CcSEcCtD
Domperidone—Headache—Capecitabine—kidney cancer	0.000114	0.00122	CcSEcCtD
Domperidone—Hypotension—Doxorubicin—kidney cancer	0.00011	0.00118	CcSEcCtD
Domperidone—Nausea—Capecitabine—kidney cancer	0.000109	0.00116	CcSEcCtD
Domperidone—Insomnia—Doxorubicin—kidney cancer	0.000107	0.00114	CcSEcCtD
Domperidone—Somnolence—Doxorubicin—kidney cancer	0.000105	0.00112	CcSEcCtD
Domperidone—Dyspepsia—Doxorubicin—kidney cancer	0.000104	0.00111	CcSEcCtD
Domperidone—Constipation—Doxorubicin—kidney cancer	0.000101	0.00108	CcSEcCtD
Domperidone—Urticaria—Doxorubicin—kidney cancer	9.36e-05	0.001	CcSEcCtD
Domperidone—Abdominal pain—Doxorubicin—kidney cancer	9.31e-05	0.000995	CcSEcCtD
Domperidone—Asthenia—Doxorubicin—kidney cancer	8.45e-05	0.000903	CcSEcCtD
Domperidone—Pruritus—Doxorubicin—kidney cancer	8.33e-05	0.000891	CcSEcCtD
Domperidone—Diarrhoea—Doxorubicin—kidney cancer	8.06e-05	0.000861	CcSEcCtD
Domperidone—Dizziness—Doxorubicin—kidney cancer	7.79e-05	0.000833	CcSEcCtD
Domperidone—Vomiting—Doxorubicin—kidney cancer	7.49e-05	0.000801	CcSEcCtD
Domperidone—Rash—Doxorubicin—kidney cancer	7.43e-05	0.000794	CcSEcCtD
Domperidone—Dermatitis—Doxorubicin—kidney cancer	7.42e-05	0.000793	CcSEcCtD
Domperidone—Headache—Doxorubicin—kidney cancer	7.38e-05	0.000789	CcSEcCtD
Domperidone—Nausea—Doxorubicin—kidney cancer	7e-05	0.000748	CcSEcCtD
Domperidone—CYP3A5—Metabolism—ITPR2—kidney cancer	8.01e-06	0.00036	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.93e-06	0.000357	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALAD—kidney cancer	7.85e-06	0.000353	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.72e-06	0.000347	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ST3GAL2—kidney cancer	7.66e-06	0.000344	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CA9—kidney cancer	7.65e-06	0.000344	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.55e-06	0.000339	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ALDH1A1—kidney cancer	7.49e-06	0.000337	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTT1—kidney cancer	7.48e-06	0.000336	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ACHE—kidney cancer	7.48e-06	0.000336	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CRABP1—kidney cancer	7.47e-06	0.000336	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—POMC—kidney cancer	7.42e-06	0.000333	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CTNNA1—kidney cancer	7.41e-06	0.000333	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—EIF4EBP1—kidney cancer	7.36e-06	0.000331	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HSPB1—kidney cancer	7.36e-06	0.000331	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PPAT—kidney cancer	7.31e-06	0.000329	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.31e-06	0.000329	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTT1—kidney cancer	7.31e-06	0.000328	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ACHE—kidney cancer	7.31e-06	0.000328	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CA9—kidney cancer	7.21e-06	0.000324	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC5A3—kidney cancer	7.18e-06	0.000323	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PGK1—kidney cancer	7.18e-06	0.000323	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.13e-06	0.00032	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—SCARB1—kidney cancer	7.08e-06	0.000318	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—LDHB—kidney cancer	7.04e-06	0.000317	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTP1—kidney cancer	7.01e-06	0.000315	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS1—kidney cancer	7.01e-06	0.000315	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ITPR2—kidney cancer	6.94e-06	0.000312	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—SCARB1—kidney cancer	6.92e-06	0.000311	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PSMD7—kidney cancer	6.87e-06	0.000309	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS1—kidney cancer	6.85e-06	0.000308	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PSMD7—kidney cancer	6.85e-06	0.000308	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TSC1—kidney cancer	6.85e-06	0.000308	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ANXA1—kidney cancer	6.85e-06	0.000308	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—APRT—kidney cancer	6.8e-06	0.000306	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—FH—kidney cancer	6.8e-06	0.000306	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PSMD7—kidney cancer	6.72e-06	0.000302	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—ABCB1—kidney cancer	6.63e-06	0.000298	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—FLT1—kidney cancer	6.63e-06	0.000298	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IGF2—kidney cancer	6.57e-06	0.000295	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.55e-06	0.000294	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN2B—kidney cancer	6.54e-06	0.000294	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—BCHE—kidney cancer	6.51e-06	0.000293	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CRABP1—kidney cancer	6.5e-06	0.000292	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—GSTM1—kidney cancer	6.44e-06	0.000289	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—SLC5A5—kidney cancer	6.43e-06	0.000289	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.4e-06	0.000288	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GPC3—kidney cancer	6.39e-06	0.000287	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—BCHE—kidney cancer	6.37e-06	0.000286	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IGF1R—kidney cancer	6.35e-06	0.000285	CbGpPWpGaD
Domperidone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.34e-06	0.000285	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTT1—kidney cancer	6.33e-06	0.000284	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ACHE—kidney cancer	6.33e-06	0.000284	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—SLC5A5—kidney cancer	6.29e-06	0.000283	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—POMC—kidney cancer	6.25e-06	0.000281	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CA2—kidney cancer	6.22e-06	0.000279	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—SLC2A1—kidney cancer	6.21e-06	0.000279	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—JUNB—kidney cancer	6.15e-06	0.000276	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PAK1—kidney cancer	6.15e-06	0.000276	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CRABP1—kidney cancer	6.13e-06	0.000275	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—RAF1—kidney cancer	6.12e-06	0.000275	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CA9—kidney cancer	6.11e-06	0.000274	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—CYP1A1—kidney cancer	6.1e-06	0.000274	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—SLC2A1—kidney cancer	6.07e-06	0.000273	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALAD—kidney cancer	6.06e-06	0.000272	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ITPR2—kidney cancer	6.05e-06	0.000272	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—IL2—kidney cancer	6.04e-06	0.000271	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—SCARB1—kidney cancer	5.99e-06	0.000269	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.97e-06	0.000268	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS1—kidney cancer	5.93e-06	0.000267	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.92e-06	0.000266	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PSMD7—kidney cancer	5.82e-06	0.000261	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.78e-06	0.00026	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ITPR2—kidney cancer	5.7e-06	0.000256	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—POMC—kidney cancer	5.68e-06	0.000255	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PGK1—kidney cancer	5.54e-06	0.000249	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.54e-06	0.000249	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTT1—kidney cancer	5.51e-06	0.000248	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—ACHE—kidney cancer	5.51e-06	0.000248	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—BCHE—kidney cancer	5.51e-06	0.000248	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—IL2—kidney cancer	5.48e-06	0.000246	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—SLC5A5—kidney cancer	5.45e-06	0.000245	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—LDHB—kidney cancer	5.44e-06	0.000244	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—SLC2A1—kidney cancer	5.26e-06	0.000236	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—HIF1A—kidney cancer	5.23e-06	0.000235	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—SCARB1—kidney cancer	5.22e-06	0.000235	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TSC2—kidney cancer	5.21e-06	0.000234	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ACHE—kidney cancer	5.2e-06	0.000234	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTT1—kidney cancer	5.2e-06	0.000234	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CRABP1—kidney cancer	5.19e-06	0.000233	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTP1—kidney cancer	5.18e-06	0.000233	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS1—kidney cancer	5.17e-06	0.000232	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.1e-06	0.000229	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PSMD7—kidney cancer	5.07e-06	0.000228	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTP1—kidney cancer	5.07e-06	0.000228	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF2—kidney cancer	5.02e-06	0.000226	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN2B—kidney cancer	5e-06	0.000225	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KDR—kidney cancer	5e-06	0.000225	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SCARB1—kidney cancer	4.92e-06	0.000221	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—ABCB1—kidney cancer	4.91e-06	0.00022	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS1—kidney cancer	4.87e-06	0.000219	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IGF1R—kidney cancer	4.86e-06	0.000218	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ITPR2—kidney cancer	4.83e-06	0.000217	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—BCHE—kidney cancer	4.8e-06	0.000216	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—ABCB1—kidney cancer	4.79e-06	0.000215	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PSMD7—kidney cancer	4.78e-06	0.000215	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—GSTM1—kidney cancer	4.76e-06	0.000214	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—SLC5A5—kidney cancer	4.75e-06	0.000213	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CA9—kidney cancer	4.71e-06	0.000212	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—RAF1—kidney cancer	4.68e-06	0.00021	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—GSTM1—kidney cancer	4.65e-06	0.000209	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—IL2—kidney cancer	4.62e-06	0.000208	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—APC—kidney cancer	4.6e-06	0.000207	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KIT—kidney cancer	4.6e-06	0.000207	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—SLC2A1—kidney cancer	4.58e-06	0.000206	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—POMC—kidney cancer	4.55e-06	0.000205	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—BCHE—kidney cancer	4.53e-06	0.000203	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—CYP1A1—kidney cancer	4.51e-06	0.000203	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.47e-06	0.000201	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.45e-06	0.0002	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.45e-06	0.0002	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.41e-06	0.000198	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—MAPK3—kidney cancer	4.41e-06	0.000198	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTT1—kidney cancer	4.4e-06	0.000198	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ACHE—kidney cancer	4.4e-06	0.000198	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTP1—kidney cancer	4.39e-06	0.000197	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—POMC—kidney cancer	4.38e-06	0.000197	CbGpPWpGaD
Domperidone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.37e-06	0.000196	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—BRAF—kidney cancer	4.33e-06	0.000194	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.32e-06	0.000194	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—IL2—kidney cancer	4.2e-06	0.000189	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—MAPK1—kidney cancer	4.2e-06	0.000189	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SCARB1—kidney cancer	4.17e-06	0.000187	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—ABCB1—kidney cancer	4.15e-06	0.000187	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS1—kidney cancer	4.13e-06	0.000185	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PSMD7—kidney cancer	4.05e-06	0.000182	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—GSTM1—kidney cancer	4.03e-06	0.000181	CbGpPWpGaD
Domperidone—DRD3—GPCR downstream signaling—PIK3CA—kidney cancer	4.01e-06	0.00018	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CRABP1—kidney cancer	4.01e-06	0.00018	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—HIF1A—kidney cancer	4e-06	0.00018	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TSC2—kidney cancer	3.99e-06	0.000179	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—KRAS—kidney cancer	3.96e-06	0.000178	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—BCHE—kidney cancer	3.84e-06	0.000172	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KDR—kidney cancer	3.82e-06	0.000172	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTP1—kidney cancer	3.82e-06	0.000172	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.82e-06	0.000172	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.79e-06	0.00017	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ITPR2—kidney cancer	3.73e-06	0.000167	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.66e-06	0.000164	CbGpPWpGaD
Domperidone—DRD3—Signaling by GPCR—PIK3CA—kidney cancer	3.64e-06	0.000164	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTGS2—kidney cancer	3.63e-06	0.000163	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RAF1—kidney cancer	3.61e-06	0.000162	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTP1—kidney cancer	3.6e-06	0.000162	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—RELA—kidney cancer	3.6e-06	0.000162	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—ERBB2—kidney cancer	3.58e-06	0.000161	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.55e-06	0.00016	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MTOR—kidney cancer	3.53e-06	0.000159	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—APC—kidney cancer	3.52e-06	0.000158	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KIT—kidney cancer	3.52e-06	0.000158	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—GSTM1—kidney cancer	3.51e-06	0.000158	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—ABCB1—kidney cancer	3.41e-06	0.000153	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ACHE—kidney cancer	3.4e-06	0.000153	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTT1—kidney cancer	3.4e-06	0.000153	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK3—kidney cancer	3.37e-06	0.000152	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—POMC—kidney cancer	3.37e-06	0.000151	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—POMC—kidney cancer	3.35e-06	0.000151	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—CYP1A1—kidney cancer	3.33e-06	0.00015	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—BRAF—kidney cancer	3.31e-06	0.000149	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CDKN1B—kidney cancer	3.31e-06	0.000149	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—GSTM1—kidney cancer	3.31e-06	0.000149	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—POMC—kidney cancer	3.29e-06	0.000148	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—IL2—kidney cancer	3.24e-06	0.000146	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SCARB1—kidney cancer	3.22e-06	0.000145	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—MAPK1—kidney cancer	3.21e-06	0.000144	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS1—kidney cancer	3.18e-06	0.000143	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PTEN—kidney cancer	3.17e-06	0.000142	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CCND1—kidney cancer	3.16e-06	0.000142	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—JUN—kidney cancer	3.15e-06	0.000142	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.14e-06	0.000141	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.14e-06	0.000141	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—CTNNB1—kidney cancer	3.13e-06	0.000141	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PSMD7—kidney cancer	3.12e-06	0.00014	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.1e-06	0.000139	CbGpPWpGaD
Domperidone—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	3.07e-06	0.000138	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTP1—kidney cancer	3.05e-06	0.000137	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PTEN—kidney cancer	3.05e-06	0.000137	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—KRAS—kidney cancer	3.03e-06	0.000136	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—BCHE—kidney cancer	2.96e-06	0.000133	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.92e-06	0.000131	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—ABCB1—kidney cancer	2.89e-06	0.00013	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—POMC—kidney cancer	2.85e-06	0.000128	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.82e-06	0.000127	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—GSTM1—kidney cancer	2.8e-06	0.000126	CbGpPWpGaD
Domperidone—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	2.79e-06	0.000125	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RAF1—kidney cancer	2.77e-06	0.000124	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—VEGFA—kidney cancer	2.75e-06	0.000124	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—RELA—kidney cancer	2.75e-06	0.000124	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—ERBB2—kidney cancer	2.74e-06	0.000123	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MTOR—kidney cancer	2.7e-06	0.000121	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTGS2—kidney cancer	2.68e-06	0.000121	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.66e-06	0.000119	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTGS2—kidney cancer	2.62e-06	0.000118	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK3—kidney cancer	2.6e-06	0.000117	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CDKN1B—kidney cancer	2.53e-06	0.000114	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MYC—kidney cancer	2.53e-06	0.000114	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—POMC—kidney cancer	2.48e-06	0.000112	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—IL2—kidney cancer	2.48e-06	0.000111	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—MAPK1—kidney cancer	2.48e-06	0.000111	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CCND1—kidney cancer	2.42e-06	0.000109	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—JUN—kidney cancer	2.41e-06	0.000108	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.39e-06	0.000108	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTP1—kidney cancer	2.35e-06	0.000106	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PTEN—kidney cancer	2.34e-06	0.000105	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—KRAS—kidney cancer	2.34e-06	0.000105	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—POMC—kidney cancer	2.34e-06	0.000105	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PTEN—kidney cancer	2.33e-06	0.000105	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PTEN—kidney cancer	2.29e-06	0.000103	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTGS2—kidney cancer	2.27e-06	0.000102	CbGpPWpGaD
Domperidone—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.23e-06	0.0001	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.23e-06	0.0001	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.18e-06	9.81e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.16e-06	9.73e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—PIK3CA—kidney cancer	2.15e-06	9.67e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.11e-06	9.47e-05	CbGpPWpGaD
Domperidone—DRD3—Signaling Pathways—TP53—kidney cancer	2.08e-06	9.35e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.05e-06	9.22e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK3—kidney cancer	1.99e-06	8.96e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PTEN—kidney cancer	1.98e-06	8.91e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—POMC—kidney cancer	1.98e-06	8.91e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTGS2—kidney cancer	1.98e-06	8.9e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MYC—kidney cancer	1.94e-06	8.71e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—MAPK1—kidney cancer	1.9e-06	8.52e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTGS2—kidney cancer	1.87e-06	8.39e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—KRAS—kidney cancer	1.79e-06	8.05e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PTEN—kidney cancer	1.73e-06	7.76e-05	CbGpPWpGaD
Domperidone—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.65e-06	7.42e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.65e-06	7.4e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PTEN—kidney cancer	1.63e-06	7.31e-05	CbGpPWpGaD
Domperidone—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.61e-06	7.26e-05	CbGpPWpGaD
Domperidone—DRD2—Signaling Pathways—TP53—kidney cancer	1.59e-06	7.15e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTGS2—kidney cancer	1.58e-06	7.1e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—POMC—kidney cancer	1.53e-06	6.87e-05	CbGpPWpGaD
Domperidone—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.4e-06	6.28e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PTEN—kidney cancer	1.38e-06	6.2e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.22e-06	5.48e-05	CbGpPWpGaD
Domperidone—ABCB1—Metabolism—PIK3CA—kidney cancer	1.22e-06	5.48e-05	CbGpPWpGaD
Domperidone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.15e-06	5.16e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PTEN—kidney cancer	1.06e-06	4.78e-05	CbGpPWpGaD
Domperidone—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.73e-07	4.37e-05	CbGpPWpGaD
Domperidone—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.51e-07	3.37e-05	CbGpPWpGaD
